The following government grants in the FederalGrants.com database contain the term small business in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| State Local Tribal and Territorial (SLTT) Reporting and Threat Information Sharing Pilot |
97.128 |
DHS-19-CISA-128-SLT-002 |
| State, Local, Tribal and Territorial (SLTT) Security Operations Center (SOC) Information Sharing and Analysis Center (ISAC) |
97.123 |
DHS-19-CISA-123-ISAC000001 |
| Circadian Patterns of Gene Expression Associated with Disease (R01 - Clinical Trial Optional) |
93.233, 93.279, 93.837, 93.838, 93.839 |
RFA-HL-20-016 |
| Limited Competition: Renewals of, and Revisions and Resubmissions to, the Longitudinal Early-onset Alzheimers Disease Study (LEADS) Cooperative Agreement (U01 Clinical Trial Not Allowed) |
93.866 |
PAR-19-338 |
| OSERS-OSEP: Technical Assistance on State Data Collection: National Technical Assistance Center to Improve State Capacity to Collect, Report, Analyze, and Use Accurate Early Childhood IDEA Data CFDA Number 84.373Z |
84.373 |
ED-GRANTS-081219-001 |
| OSERS-OSEP: Technical Assistance on State Data Collection--National Technical Assistance Center To Improve State Capacity To Collect, Report, Analyze, and Use Accurate IDEA Part B Data CFDA Number 84.373Y |
84.373 |
ED-GRANTS-081219-002 |
| FY2020 SBIR/STTR Phase I Release 1 |
81.049 |
DE-FOA-0002145 |
| BLM AK Wildland Urban Interface (WUI) Community Fire Assistance |
15.228 |
L19AS00104 |
| OSERS-OSEP: Technical Assistance and Dissemination To Improve Services and Results for Children With Disabilities--National Technical Assistance Center for Systemic Improvement Catalog of Federal Domestic Assistance |
84.326 |
ED-GRANTS-080819-002 |
| The Biological Mechanisms of Metformin Effects on Aging and Longevity (R01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-20-044 |
| Technologies to Advance Precision Medicine Diagnosis and Treatment of Infertility, Reproductive Tract and Gynecologic Disorders Affecting Fertility (R43/R44 Clinical Trial Optional) |
93.865 |
RFA-HD-20-010 |
| OSERS-OSEP: Technical Assistance and Dissemination Center for the Development and Implementation of High-Quality Instruction, Interventions, and Services for Children with Disabilities CFDA Number 84.326C |
84.326 |
ED-GRANTS-080719-001 |
| SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Not Allowed |
93.121, 93.173, 93.233, 93.242, 93.273, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.866, 93.867 |
PAR-19-333 |
| SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed |
93.113, 93.121, 93.172, 93.173, 93.233, 93.242, 93.273, 93.286, 93.350, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.855, 93.859, 93.866, 93.867 |
PAR-19-334 |
| SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Required |
93.173, 93.233, 93.242, 93.273, 93.837, 93.838, 93.839, 93.840, 93.853, 93.866, 93.867 |
PAR-19-335 |
| Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-19-330 |
| Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) |
93.233, 93.340, 93.837, 93.838, 93.839 |
PAR-19-329 |
| Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-19-328 |
| Small Business Development Centers |
59.037 |
OSBDC-2020-01 |
| Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) |
93.279 |
PAR-19-327 |
| OSERS-OSEP: Educational Technology, Media, and Materials for Individuals with Disabilities: National Center on Accessible Educational Materials for Learning CFDA Number 84.327Z |
84.327 |
ED-GRANTS-080119-001 |
| US Children with Perinatal HIV who were Born Internationally (R01 Clinical Trial Optional) |
93.865 |
RFA-HD-20-006 |
| Palliative Care in Home and Community Settings (R01 Clinical Trial Optional) |
93.361 |
PAR-19-321 |
| Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trials Optional) |
93.396 |
RFA-CA-19-063 |
| Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) |
93.113, 93.143 |
RFA-ES-19-011 |
| Building Resources for the Basic Biology of Aging in Health Disparities Research (R24 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-20-035 |
| Catalyst Award In Diabetes, Endocrinology and Metabolic Diseases (DP1 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-19-014 |
| Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional) |
93.396 |
RFA-CA-19-061 |
| Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional) |
93.396 |
RFA-CA-19-062 |
| Palliative Care in Home and Community Settings (R21 Clinical Trial Optional) |
93.361 |
PAR-19-320 |
| The Role of Stem/Progenitor Cells in the Pathogenesis and Treatment of Gynecologic Disorders (R21 Clinical Trial Optional) |
93.865 |
RFA-HD-20-007 |
| Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) |
93.395, 93.396, 93.399 |
PAR-19-325 |
| Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed) |
93.353, 93.393, 93.396 |
RFA-CA-19-046 |
| Research on the Use of Autonomy and Unmanned Vehicles in Support of USAF Operations |
12.800 |
USAFA-BAA-2015-CALL-0008 |
| NIDDK Central Repositories Non-renewable Sample Access (X01 Clinical Trial Not Allowed) |
93.847 |
PAR-19-319 |
| Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional) |
93.353, 93.393, 93.396 |
RFA-CA-19-045 |
| Central Coordinating Site for the Polycystic Kidney Disease Research and Translation Core Centers (U24 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-19-011 |
| Polycystic Kidney Disease Research and Translation Core Centers (U54 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-19-010 |
| Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01-Clinical Trial Optional) |
93.279 |
PAR-19-318 |
| FY 20 and FY21 SBIR Phase I RFA |
10.212 |
USDA-NIFA-SBIR-006790 |
Search Results 5361-5400 of 21019
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 [Next] |
